Technical Analysis for MGNX - MacroGenics, Inc.

Grade Last Price % Change Price Change
F 3.24 0.93% 0.03
MGNX closed up 0.93 percent on Friday, November 22, 2024, on 73 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
6 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down

Date Alert Name Type % Chg
NR7 Range Contraction 0.00%
NR7-2 Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
NR7 Range Contraction 0.93%
Wide Bands Range Expansion 0.93%
Down 3 Days in a Row Weakness 0.93%
Down 4 Days in a Row Weakness 0.93%
Down 5 Days in a Row Weakness 0.93%
Oversold Stochastic Weakness 0.93%

   Recent Intraday Alerts

Alert Time
Possible NR7 about 14 hours ago
Up 3% about 16 hours ago
Up 2% about 18 hours ago
60 Minute Opening Range Breakout about 18 hours ago
Fell Below Previous Day's Low about 18 hours ago

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

MacroGenics, Inc. Description

MacroGenics is a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of cancer and autoimmune diseases. The company generates its pipeline of product candidates from its proprietary suite of next-generation antibody technology platforms, which it believes improve the performance of monoclonal antibodies and antibody-derived molecules. The company creates both differentiated molecules that are directed to novel cancer targets, as well as "bio-betters," which are drugs designed to improve upon marketed medicines. The combination of MacroGenics' technology platforms and antibody engineering expertise has allowed the company to generate promising product candidates and enter into several strategic collaborations with global pharmaceutical and biotechnology companies.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Biopharmaceutical Cancer Life Sciences Biology Immunology Immune System Autoimmune Disease Antibodies Treatment Of Cancer Monoclonal Antibodies Monoclonal Antibody Antibody Novel Cancer

Is MGNX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 21.88
52 Week Low 2.9511
Average Volume 637,553
200-Day Moving Average 7.95
50-Day Moving Average 3.64
20-Day Moving Average 3.73
10-Day Moving Average 3.64
Average True Range 0.30
RSI (14) 37.89
ADX 17.57
+DI 19.23
-DI 24.27
Chandelier Exit (Long, 3 ATRs) 4.21
Chandelier Exit (Short, 3 ATRs) 4.04
Upper Bollinger Bands 4.49
Lower Bollinger Band 2.97
Percent B (%b) 0.18
BandWidth 40.76
MACD Line -0.11
MACD Signal Line -0.01
MACD Histogram -0.099
Fundamentals Value
Market Cap 200.98 Million
Num Shares 62 Million
EPS 0.81
Price-to-Earnings (P/E) Ratio 4.00
Price-to-Sales 9.37
Price-to-Book 5.54
PEG Ratio 0.01
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.48
Resistance 3 (R3) 3.48 3.39 3.44
Resistance 2 (R2) 3.39 3.33 3.40 3.43
Resistance 1 (R1) 3.32 3.29 3.36 3.32 3.41
Pivot Point 3.23 3.23 3.25 3.24 3.23
Support 1 (S1) 3.16 3.17 3.20 3.16 3.07
Support 2 (S2) 3.07 3.13 3.08 3.05
Support 3 (S3) 3.00 3.07 3.04
Support 4 (S4) 3.00